Antikörper gegen OPGL
Patent europeic · EP2270052 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP2270052
- Numer da la dumonda
- EP10181323
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 25-06-2002
- Publitgà
- 05-01-2011
- Concedì
- 28-03-2018
- Stritgà
- 01-07-2022
- Motiv
- Durada maximala cuntanschida
- Classas IPC
- C07K 16/28 (2006.01)A61K 39/395 (2006.01)G01N 33/53 (2006.01)//A61P 19/08 (2006.01)
- Prioritad
- US 301172 P 26.06.2001
- Derivà da
- EP09156995
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-07-2022
Durada maximala cuntanschida
Published in Swissreg on 01.07.2022
- 22-09-2021
Transferì
- Owner
- Amgen, Inc., One Amgen Center Drive, Naukstio 27/4-A, Thousands Oaks, CA 91320, USA, Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA → Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA, Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
Published in Swissreg on 22.09.2021
- 28-03-2018
Concedì
Published in Swissreg on 28.03.2018
Partidas
Possessur
Inventur
Boyle, William
Malibu, CA 90265, US
Martin, Francis
Newbury Park, CA 91320, US
Corvalan, Jose
Foster City, CA 94404, US
Davis, Geoffrey
Burlingame, CA 94010, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.